Literature DB >> 2182303

Infectious complications of indwelling long-term central venous catheters.

D E Clarke1, T A Raffin.   

Abstract

The long-term CVC allows patients with a variety of diseases to lead a more normal and pain-free life. The use of these catheters has become commonplace in most hospitals, and the physician caring for patients in the ICU will be caring for increasing numbers of patients with an indwelling long-term CVC. Infections of these catheters can be manifested in many different ways: tunnel infections, exit site infections, catheter-related bacteremia, and septic thrombophlebitis. The overwhelming majority of these infections are caused by coagulase-negative staphylococci, but physicians should be aware of the wide variety of organisms that can infect the long-term CVC. The diagnosis of long-term CVC sepsis can be difficult, but the use of quantitative blood cultures for catheters left in place and the Maki method for culturing those catheters that are removed will aid physicians in their quest for diagnostic certainty. The great majority of catheter infections will resolve with antibiotic therapy alone without the need for catheter removal, but there are important exceptions to this general rule. Tunnel infections and fungal long-term CVC infections often require catheter removal for their resolution; septic thrombophlebitis and CR-SCVT require the addition of anticoagulation or fibrinolytic therapy to antibiotic regimens for resolution of the infection, and surgical debridement may be warranted if these modalities fail to resolve the infection.

Entities:  

Mesh:

Year:  1990        PMID: 2182303     DOI: 10.1378/chest.97.4.966

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  A simple, effective and safe method for central venous catheter replacement.

Authors:  A G Tsiotou; G H Sakorafas
Journal:  Ann R Coll Surg Engl       Date:  2001-01       Impact factor: 1.891

2.  Vitronectin-binding staphylococci enhance surface-associated complement activation.

Authors:  F Lundberg; T Lea; A Ljungh
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis.

Authors:  Y Siegman-Igra; A M Anglim; D E Shapiro; K A Adal; B A Strain; B M Farr
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  [Indications, technique and complications of port implantation].

Authors:  L Haeder; J Jähne
Journal:  Chirurg       Date:  2013-07       Impact factor: 0.955

5.  Skin versus hub cultures to predict colonization and infection of central venous catheter in intensive care patients.

Authors:  B Guidet; I Nicola; V Barakett; J M Gabillet; E Snoey; J C Petit; G Offenstadt
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

6.  Relevance of culturing Candida species from intravascular catheters.

Authors:  R Khatib; J A Clark; L E Briski; F M Wilson
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

Review 7.  Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part I.

Authors:  C R Thomas; L V Wood; J G Douglas; K J Stelzer; W Koh; R Panicker
Journal:  J Natl Med Assoc       Date:  1994-10       Impact factor: 1.798

8.  Successful treatment of Pseudomonas paucimobilis haemodialysis catheter-related sepsis without catheter removal.

Authors:  D Saltissi; D J Macfarlane
Journal:  Postgrad Med J       Date:  1994-01       Impact factor: 2.401

9.  Clonal expansion of Staphylococcus epidermidis strains causing Hickman catheter-related infections in a hemato-oncologic department.

Authors:  J L Nouwen; A van Belkum; S de Marie; J Sluijs; J J Wielenga; J A Kluytmans; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Catheter-related infection in gastrointestinal fistula patients.

Authors:  Ge-Fei Wang; Jian-An Ren; Jun Jiang; Cao-Gan Fan; Xin-Bo Wang; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.